Mabel Mardones, MD, Rocky Mountain Cancer Centers, discusses the future of HR+/HER2– breast cancer treatment, focusing on the importance of biomarkers and the potential of SIRDs to improve patient ...
Johnson & Johnson has announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization for BALVERSA®â–¼ (erdafitinib) as a monotherapy for the treatment ...
A Michigan State University researcher's new model for studying breast cancer could help scientists better understand why and ...
Cleveland Clinic researchers are presenting updated findings from their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.
A new type of mammogram that has shown promise in clinical trials could detect more potential cancers in women with dense breasts. The radiologist who conducted a trial at the Mayo Clinic shows how ...
An FDA panel on Thursday endorsed a cryoablation system as an alternative to surgery for some early breast cancer patients.
University of Kentucky Markey Cancer Center researchers identified a protein that could be key to developing new treatments ...
A new genetic study from researchers at Michigan State University could help scientists gain a deeper understanding of where ...
Ahead of the Bengals-Giants game on Sunday, Oct. 13, Jill joined the program to discuss her history with breast cancer and urge viewers to consider genetic testing if they're high risk — a step ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback